title: The value of branded proton pump inhibitors: formulary considerations.
abstract: The prevalence of gastroesophageal reflux disease (GERD) continues to rise, placing an increasing burden on our health care system. Proton pump inhibitors (PPIs) are the most effective and widely used therapy for GERD. Many PPIs are now available in generic and over-the-counter forms, and managed care formularies often choose these as their preferred drug for GERD treatment. However, newer-generation branded PPIs, as a result of differences in their pharmacokinetic and pharmacodynamic profiles, may offer clinical advantages over generic PPIs. This article discusses these differences and the advantages they offer and suggests possible ways to incorporate the newer PPIs into formularies.
authors.forename: David A
authors.initials: DA
authors.lastname: Peura
authors.forename: Rosemary R
authors.initials: RR
authors.lastname: Berardi
authors.forename: Javier
authors.initials: J
authors.lastname: Gonzalez
authors.forename: Louis
authors.initials: L
authors.lastname: Brunetti